Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years

By The Conversation | December 21, 2021

For peo­ple with post-trau­­mat­ic stress dis­or­der, recall­ing mem­o­ries of phys­i­cal or sex­u­al assault, com­bat or dis­­as­ter-relat­ed events can induce intense anx­i­ety or pan­ic attacks as well as debil­i­tat­ing flash­backs. In the U.S., about 7% of peo­ple suf­fer from PTSD and lose an aver­age of about four work­ing days each month as a result. Trau­­ma-spe­­cif­ic psychotherapy,…

Read More

Study finds MDMA-assisted therapy to be safe and highly effective to treat severe PTSD

By SharpBrains | May 18, 2021

The First Phase 3 Suc­cess for Psy­che­delics Will Pave the Way for an Indus­try (Bar­ron’s): Post-trau­­mat­ic stress dis­or­der is a crip­pling, hard-to-treat psy­chi­atric afflic­tion. Amer­i­ca spends bil­lions of dol­lars year­ly just on the vet­er­ans who suf­fer from PTSD. So it’s heart­en­ing to see the report of a promis­ing new treat­ment, pub­lished Mon­day in Nature Medicine.

Read More